ME Therapeutics HoldingsME Therapeutics Holdings
MT

ME Therapeutics Holdings

Biotechnology company developing novel cancer fighting drugs that reprogram and redirect immune cells to fight cancer.

Website
2017Inactive
Advertise here

About

ME Therapeutics Holdings Inc. is a publicly listed biotechnology company focused on developing innovative cancer therapies. Their approach involves reprogramming and redirecting immune cells to effectively combat cancer. The company is listed on the CSE (METX) and FSE (Q9T).

Technology stack

detected 2026-06-03
Est. monthly stack spend~$70/mo
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does ME Therapeutics Holdings do?

ME Therapeutics Holdings Inc. is a publicly listed biotechnology company focused on developing innovative cancer therapies. Their approach involves reprogramming and redirecting immune cells to effectively combat cancer. The company is listed on the CSE (METX) and FSE (Q9T).

How much funding has ME Therapeutics Holdings raised?

ME Therapeutics Holdings has raised a total of $500K in funding. The most recent round on record is Private Placement.

Where is ME Therapeutics Holdings headquartered?

ME Therapeutics Holdings is headquartered in Vancouver, British Columbia, Canada.

When was ME Therapeutics Holdings founded?

ME Therapeutics Holdings was founded in 2017.

What industry does ME Therapeutics Holdings operate in?

ME Therapeutics Holdings operates in Biotechnology, Healthcare, Pharmaceuticals, Cancer Research, Biotech, MedTech.

What is ME Therapeutics Holdings's current status?

ME Therapeutics Holdings's current operating status is: Inactive.